Provided by Tiger Trade Technology Pte. Ltd.

Shuttle Pharmaceuticals Inc

3.46
-0.9100-20.82%
Post-market: 3.32-0.1400-4.05%19:57 EDT
Volume:606.09K
Turnover:2.61M
Market Cap:2.02M
PE:-0.06
High:3.88
Open:3.88
Low:3.40
Close:4.37
52wk High:55.90
52wk Low:3.27
Shares:585.13K
Float Shares:582.38K
Volume Ratio:6.58
T/O Rate:104.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-57.1430
EPS(LYR):-71.6000
ROE:-326.36%
ROA:-81.65%
PB:0.61
PE(LYR):-0.05

Loading ...

Shuttle Pharmaceuticals Holdings Inc trading halted, news pending

TIPRANKS
·
Jun 11

Shuttle Pharma to execute 10-for-1 reverse stock split on June 11

Reuters
·
Jun 09

Shuttle Pharmaceuticals files Form 3 for Co-CEO Ryan Trasolini

Reuters
·
Jun 02

Shuttle Pharmaceuticals shareholders approve reverse stock split authorization at annual meeting

Reuters
·
May 27

Shuttle Pharmaceuticals Q1 EPS $(0.43) Up From $(7.60) YoY

Benzinga
·
May 16

Shuttle Pharma Q1 FY26 net loss narrows 29% to $2.15 million

Reuters
·
May 16

Shuttle Pharmaceuticals closes United Dogecoin acquisition, creating public Dogecoin miner platform

Reuters
·
May 08

E.f. Hutton & Co. Serves as Exclusive M&a Advisor and Placement Agent on Completed Shuttle Pharmaceuticals–United Dogecoin Merger to Create the Largest Public Dogecoin Miner

THOMSON REUTERS
·
May 08

Shuttle Pharmaceuticals agrees to merge with Dogecoin miner United Dogecoin

Reuters
·
May 01

Shuttle Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 11

Shuttle Pharma FY25 net loss widens 28% to $11.7 million; operating loss deepens to $11.9 million

Reuters
·
Apr 01

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Shuttle Pharmaceuticals closes USD 3.5 million public offering

Reuters
·
Mar 12

Shuttle Pharmaceuticals announces USD 3.5 million public offering

Reuters
·
Mar 11

Shuttle Pharma FY2025 general and administrative expenses surge to USD 5.2–5.8 million from USD 1.4 million

Reuters
·
Feb 18

Shuttle Pharmaceuticals Extends Consulting Agreement With Interim Co-CEO at $20,000 Per Month

Reuters
·
Feb 03

Shuttle Pharmaceuticals Names Yuying Liang as Finance Chief

Dow Jones
·
Jan 13

BRIEF-Shuttle Pharmaceuticals Holdings Inc - Appoints Yuying Liang As CFO - SEC Filing

Reuters
·
Jan 13

Shuttle Pharmaceuticals Holdings Inc. Files Initial Beneficial Ownership Statement for CFO Yuying Liang

Reuters
·
Jan 13

Shuttle Pharmaceuticals Issues 320,496 Unregistered Shares in Asset Purchase Deal

Reuters
·
Dec 30, 2025